3750:HKEXContemporary Amperex Technology Co., Limited Class H Analysis
Data as of 2026-03-14 - not real-time
HK$621.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Technical momentum is firmly bullish, with the short‑term moving average comfortably above the mid‑term average and the long‑term average still lagging, while the MACD histogram remains strongly positive and volume is on an upward trend. However, the RSI has entered overbought territory, suggesting that a short‑term pull‑back could test the nearby support level before any further upside.
Fundamentally, the company is delivering robust top‑line growth and expanding margins, outpacing the industry PE benchmark and generating ample free cash flow to sustain its modest dividend payout. The balance sheet is strong with cash far exceeding debt, and forward earnings estimates point to a healthier valuation multiple, supporting a continued growth narrative despite the current market price appearing slightly stretched.
Fundamentally, the company is delivering robust top‑line growth and expanding margins, outpacing the industry PE benchmark and generating ample free cash flow to sustain its modest dividend payout. The balance sheet is strong with cash far exceeding debt, and forward earnings estimates point to a healthier valuation multiple, supporting a continued growth narrative despite the current market price appearing slightly stretched.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Bullish MACD and rising volume
- RSI indicating potential short‑term pull‑back
- Proximity to near‑term resistance
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth and expanding margins
- Forward earnings multiple below current valuation
- Robust cash generation and low payout ratio
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Leadership position in the EV battery market
- Sustainable dividend supported by cash flow
- High return on equity and continued industry tailwinds
Key Metrics & Analysis
Financial Health
Revenue Growth36.60%
Profit Margin17.04%
P/E Ratio33.8
ROE23.83%
ROA5.40%
Debt/Equity32.23
P/B Ratio7.3
Op. Cash FlowHK$133.2B
Free Cash FlowHK$66.6B
Industry P/E29.1
Technical Analysis
TrendBullish
RSI73.6
SupportHK$470.20
ResistanceHK$623.00
MA 20HK$527.66
MA 50HK$505.85
MA 200HK$460.45
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair ValueHK$604.02
Target PriceHK$625.69
Upside/Downside0.75%
GradeOvervalued
TypeGrowth
Dividend Yield0.58%
Risk Assessment
Beta0.65
Volatility52.04%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.